TGM2 Antibody | CSB-PA023462ESR2HU

(No reviews yet) Write a Review
SKU:
CSB-PA023462ESR2HU
Availability:
3 to 7 Working Days
  • TGM2 Antibody
  • Western blot<br />
 All lanes: Protein-glutamine gamma-glutamyltransferase 2 antibody at 8µg/ml<br />
 Lane 1: Hela whole cell lysate<br />
 Lane 2: HepG2 whole cell lysate<br />
 Secondary<br />
 Goat polyclonal to rabbit IgG at 1/10000 dilution<br />
 Predicted band size: 78, 62, 39 kDa<br />
 Observed band size: 78 kDa<br />
  • Immunohistochemistry of paraffin-embedded human breast cancer using CSB-PA023462ESR2HU at dilution of 1:100
€230.00 - €317.10

Description

TGM2 Antibody | CSB-PA023462ESR2HU | Cusabio

TGM2 Antibody is Available at Gentaur Genprice with the fastest delivery.

Online Order Payment is possible or send quotation to info@gentaur.com.

Product Type: Polyclonal Antibody

Target Names: TGM2

Aliases: Protein-glutamine gamma-glutamyltransferase 2 (EC 2.3.2.13) (Tissue transglutaminase) (Transglutaminase C) (TG (C) ) (TGC) (TGase C) (Transglutaminase H) (TGase H) (Transglutaminase-2) (TGase-2), TGM2

Background: Catalyzes the cross-linking of proteins and the conjugation of polyamines to proteins.

Isotype: IgG

Conjugate: Non-conjugated

Clonality: Polyclonal

Uniport ID: P21980

Host Species: Rabbit

Species Reactivity: Human

Immunogen: Recombinant Human Protein-glutamine gamma-glutamyltransferase 2 protein (438-687AA)

Immunogen Species: Human

Applications: ELISA, WB, IHC

Tested Applications: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200

Purification Method: Antigen Affinity Purified

Dilution Ratio1: ELISA:1:2000-1:10000

Dilution Ratio2: WB:1:500-1:2000

Dilution Ratio3: IHC:1:20-1:200

Dilution Ratio4:

Dilution Ratio5:

Dilution Ratio6:

Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

Form: Liquid

Storage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Initial Research Areas: Cell Biology

Research Areas: Cancer;Cell biology;Immunology;Metabolism;Signal transduction

View AllClose

0 Reviews

View AllClose